Serum MicroRNA-125b as a Potential Biomarker for Glioma Diagnosis

详细信息    查看全文

• 作者：XiangTai Wei ; Duo Chen ; Tao Lv ; Gang Li ; ShengTao Qu
• 关键词：Glioma ; Biomarker ; Diagnosis ; MicroRNA ; 125b ; Serum ; Meta ; analysis
• 刊名：Molecular Neurobiology
• 出版年：2016
• 出版时间：January 2016
• 年：2016
• 卷：53
• 期：1
• 页码：163-170
• 全文大小：906 KB
• 参考文献：1.Parkin DM, Pisani P, Ferlay J (1999) Global cancer statistics. CA: Cancer J Clin 49(1):33–64, 31
  2.Turner JD, Williamson R, Almefty KK, Nakaji P, Porter R, Tse V, Kalani MY (2010) The many roles of microRNAs in brain tumor biology. Neurosurg Focus 28(1):E3. doi:10.​3171/​2009.​10.​FOCUS09207 CrossRef PubMed
  3.Gladson CL, Prayson RA, Liu WM (2010) The pathobiology of glioma tumors. Annu Rev Pathol 5:33–50. doi:10.​1146/​annurev-pathol-121808-102109 CrossRef PubMed PubMedCentral
  4.Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109. doi:10.​1007/​s00401-007-0243-4 CrossRef PubMed PubMedCentral
  5.Ilhan-Mutlu A, Wagner L, Preusser M (2013) Circulating biomarkers of CNS tumors: an update. Biomark Med 7(2):267–285. doi:10.​2217/​bmm.​13.​12 CrossRef PubMed
  6.Mann DV, Edwards R, Ho S, Lau WY, Glazer G (2000) Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol 26(5):474–479. doi:10.​1053/​ejso.​1999.​0925 CrossRef
  7.Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL (2008) Protein biomarker identification in the CSF of patients with CNS lymphoma. J Clin Oncol: Off J Am Soc Clin Oncol 26(1):96–105. doi:10.​1200/​JCO.​2007.​12.​1053 CrossRef
  8.Kersten MJ, Evers LM, Dellemijn PL, van den Berg H, Portegies P, Hintzen RQ, van Lier RA, von dem Borne AE, van Oers RH (1996) Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies. Blood 87(5):1985–1989PubMed
  9.Schroers R, Baraniskin A, Heute C, Kuhnhenn J, Alekseyev A, Schmiegel W, Schlegel U, Pels HJ (2010) Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas. Eur J Haematol 85(3):236–242. doi:10.​1111/​j.​1600-0609.​2010.​01475.​x CrossRef PubMed
  10.Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853–858. doi:10.​1126/​science.​1064921 CrossRef PubMed
  11.Jovanovic M, Hengartner MO (2006) miRNAs and apoptosis: RNAs to die for. Oncogene 25(46):6176–6187. doi:10.​1038/​sj.​onc.​1209912 CrossRef PubMed
  12.Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103(7):2257–2261. doi:10.​1073/​pnas.​0510565103 CrossRef PubMed PubMedCentral
  13.Hwang HW, Mendell JT (2007) MicroRNAs in cell proliferation, cell death, and tumorigenesis. Br J Cancer 96(Suppl):R40–R44PubMed
  14.Mar-Aguilar F, Mendoza-Ramirez JA, Malagon-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodriguez-Padilla C, Resendez-Perez D (2013) Serum circulating microRNA profiling for identification of potential breast cancer biomarkers. Dis Markers 34(3):163–169. doi:10.​3233/​dma-120957 CrossRef PubMed PubMedCentral
  15.Mar-Aguilar F, Luna-Aguirre CM, Moreno-Rocha JC, Araiza-Chavez J, Trevino V, Rodriguez-Padilla C, Resendez-Perez D (2013) Differential expression of miR-21, miR-125b and miR-191 in breast cancer tissue. Asia-Pacific J Clin Oncol 9(1):53–59. doi:10.​1111/​j.​1743-7563.​2012.​01548.​x CrossRef
  16.Vriens MR, Weng J, Suh I, Huynh N, Guerrero MA, Shen WT, Duh QY, Clark OH, Kebebew E (2012) MicroRNA expression profiling is a potential diagnostic tool for thyroid cancer. Cancer 118(13):3426–3432. doi:10.​1002/​cncr.​26587 CrossRef PubMed
  17.Ichimi T, Enokida H, Okuno Y, Kunimoto R, Chiyomaru T, Kawamoto K, Kawahara K, Toki K, Kawakami K, Nishiyama K, Tsujimoto G, Nakagawa M, Seki N (2009) Identification of novel microRNA targets based on microRNA signatures in bladder cancer. International journal of cancer Journal international du cancer 125(2):345–352. doi:10.​1002/​ijc.​24390 CrossRef PubMed
  18.Zhang Y, Jiang L (2014) CRP 1059 G/C and 1846G/A polymorphisms and cancer risk: A meta-analysis of 26,634 subjects. Clin Res Hepatol Gastroenterol. doi:10.​1016/​j.​clinre.​2014.​04.​002
  19.Smirnova L, Grafe A, Seiler A, Schumacher S, Nitsch R, Wulczyn FG (2005) Regulation of miRNA expression during neural cell specification. Eur J Neurosci 21(6):1469–1477. doi:10.​1111/​j.​1460-9568.​2005.​03978.​x CrossRef PubMed
  20.Si H, Sun X, Chen Y, Cao Y, Chen S, Wang H, Hu C (2013) Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer. J Cancer Res Clin Oncol 139(2):223–229. doi:10.​1007/​s00432-012-1315-y CrossRef PubMed PubMedCentral
  21.Ma Y, Tian Z, Zhang W (2012) Circulating miR-125b is a novel biomarker for screening non-small-cell lung cancer and predicts poor prognosis. J Cancer Res Clin Oncol 138(12):2045–2050. doi:10.​1007/​s00432-012-1285-0 CrossRef
  22.(2002) International ethical guidelines for biomedical research involving human subjects. Bull Med Ethics 182:17–23
  23.Baraniskin A, Kuhnhenn J, Schlegel U, Maghnouj A, Zollner H, Schmiegel W, Hahn S, Schroers R (2012) Identification of microRNAs in the cerebrospinal fluid as biomarker for the diagnosis of glioma. Neuro-Oncology 14(1):29–33. doi:10.​1093/​neuonc/​nor169 CrossRef PubMed PubMedCentral
  24.Zamora J, Abraira V, Muriel A, Khan K, Coomarasamy A (2006) Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 6:31. doi:10.​1186/​1471-2288-6-31 CrossRef PubMed PubMedCentral
  25.Mitchell AJ, Vaze A, Rao S (2009) Clinical diagnosis of depression in primary care: a meta-analysis. Lancet 374(9690):609–619. doi:10.​1016/​S0140-6736(09)60879-5 CrossRef PubMed
  26.Deeks JJ (2001) Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 323(7305):157–162CrossRef PubMed PubMedCentral
  27.Monzo M, Navarro A, Bandres E, Artells R, Moreno I, Gel B, Ibeas R, Moreno J, Martinez F, Diaz T, Martinez A, Balague O, Garcia-Foncillas J (2008) Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res 18(8):823–833. doi:10.​1038/​cr.​2008.​81 CrossRef PubMed
  28.Walter SD (2002) Properties of the summary receiver operating characteristic (SROC) curve for diagnostic test data. Stat Med 21(9):1237–1256. doi:10.​1002/​sim.​1099 CrossRef PubMed
  29.Chan JA, Krichevsky AM, Kosik KS (2005) MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65(14):6029–6033. doi:10.​1158/​0008-5472.​CAN-05-0137 CrossRef PubMed
  
• 作者单位：XiangTai Wei (1)
  Duo Chen (1)
  Tao Lv (1)
  Gang Li (1)
  ShengTao Qu (1)
  
  1. Department of Neurosurgery, Shengjing Hospital of China Medical University, Shenyang, 110004, China
  
• 刊物主题：Neurosciences; Neurobiology; Cell Biology; Neurology;
• 出版者：Springer US
• ISSN：1559-1182

文摘

Biomarkers in blood have become increasingly appreciated in the diagnosis of glioma, but most of their diagnostic accuracy was not high enough to be used widely in a clinical context. MicroRNA-125b (miRNA-125b, miR-125b), a member of microRNA cluster, is widely considered as ideal biomarkers for clinical diagnosis in various human cancers. In the current study, we first explored the diagnostic value of serum miR-125b for glioma in a Chinese population, which has not been studied yet. Additionally, we conducted a meta-analysis to assess the diagnostic accuracy of miR-125b in human cancers. Serum miR-125b from the 33 patients with glioma (WHO grades I–IV) and 33 healthy controls were compared. Our results showed that the serum miR-125b level was significantly lower in glioma patients when compared with normal population, and an obvious decreasing trend of miR-125b level along tumor stages was found. The receiver operating characteristic (ROC) curve analysis of the accuracy in distinguishing glioma cancer patients from healthy controls yielded an area under the curve (AUC) value of 0.839 (95 % confidence interval (CI), 0.743–0.935). When glioma patients at different stages were compared with normal controls, the AUC values of WHO grade II (0.868) and WHO grade III–IV (0.959) were higher than WHO grade I (0.691). In the meta-analysis, the overall sensitivity, specificity, and AUC for miR-125b in human cancers diagnosis were 82 % (95 % CI, 76–87 %), 77 % (95 % CI, 70–84 %), and 0.84 (95 % CI, 0.81–0.87), respectively. The results of the present study suggested that miR-125b could be a potential biomarker with relatively high accuracy in the diagnosis of glioma as well as other human cancers.